The numbers HUM said it expected, in its earnings releases of the last 3 years, next to what it then reported for the same period. Each target links to the sentence in the release; each result to the 10-Q or 10-K it was first reported in.
Of 1 range targets with a reported result: 0 came in above the last range given, 0 within it, 1 below it.
Of 2 minimum or maximum targets ("at least", "no more than") with a reported result: 1 were kept, 1 were not.
| Target | What the company said | Reported | Result |
|---|---|---|---|
| Diluted EPS Fiscal 2026 |
Given at least $8.89 release 2026-02-11
Lowered at least $8.36 release 2026-04-29
Lowered at least $6.52 release 2026-07-29
Raised at least $15.09 release 2026-11-06
|
– | Not reported yet |
The company's wordsIntroduces FY 2026 GAAP EPS guidance of 'at least $8.89'; 'at least $9.00' on an Adjusted basis; the anticipated year-over-year decline results from the Star Ratings headwind for Bonus Year 2026, net of mitigation release 2026-02-11 Affirms Full Year 2026 Adjusted Financial Guidance … Affirms Adjusted FY 2026 GAAP EPS guidance of 'at least $9.00'; while revising GAAP EPS guidance to 'at least $8.36' from the previous estimate of 'at least $8.89' release 2026-04-29 Affirms Full Year 2026 Adjusted Financial Guidance … Affirms FY 2026 Adjusted EPS guidance of 'at least $9.00'; while revising GAAP EPS guidance to 'at least $6.52' from the previous estimate of 'at least $8.36' release 2026-07-29 Raises FY 2026 Adjusted EPS guidance to now be 'at least $9.50', up from the previous expectation of 'at least $9.00'; while revising GAAP EPS guidance to 'at least $15.09', up from the previous estimate of 'at least $6.52' release 2026-11-06 | |||
| Diluted EPS (company-defined) Fiscal 2026 |
Given at least $9.00 release 2026-02-11
Kept at least $9.00 release 2026-04-29
Kept at least $9.00 release 2026-07-29
Raised at least $9.50 release 2026-11-06
|
– | No standard number |
The company's wordsProvided FY 2026 Adjusted EPS outlook of ‘at least $9’ , with the anticipated year over year decline driven by the previously communicated BY 2026 Star Ratings headwind, net of mitigation (Appendix A) release 2026-02-11 Affirms Adjusted FY 2026 GAAP EPS guidance of 'at least $9.00'; while revising GAAP EPS guidance to 'at least $8.36' from the previous estimate of 'at least $8.89' release 2026-04-29 Affirms FY 2026 Adjusted EPS guidance of 'at least $9.00'; while revising GAAP EPS guidance to 'at least $6.52' from the previous estimate of 'at least $8.36' release 2026-07-29 Raises FY 2026 Adjusted EPS guidance to now be 'at least $9.50', up from the previous expectation of 'at least $9.00'; while revising GAAP EPS guidance to 'at least $15.09', up from the previous estimate of 'at least $6.52' release 2026-11-06 | |||
| Diluted EPS (company-defined) Fiscal 2025 (ended 2025-12-31) |
Given $15.88 release 2025-02-11
Raised $16.25 release 2025-04-30
Raised $17.00 release 2025-07-30
Kept $17.00 release 2025-11-05
|
– | No standard number |
The company's wordsAffirms previous commentary of Adjusted FY 2025 EPS guidance to be 'at least in line with 2024 results'; anticipating GAAP EPS of approximately $15.88, or approximately $16.25 on an Adjusted basis, inclusive of incremental investments to support operational excellence release 2025-02-11 Affirms Adjusted FY 2025 EPS guidance of 'approximately $16.25'; while revising GAAP EPS to 'approximately $14.68' from the previous estimate of 'approximately $15.88' release 2025-04-30 Raises Full Year 2025 Adjusted EPS and Revenue Guidance … Updates FY 2025 GAAP EPS guidance to 'approximately $13.77' from the previous estimate of 'approximately $14.68'; raises Adjusted FY 2025 EPS guidance to 'approximately $17.00', up from the previous 'approximately $16.25' guidance release 2025-07-30 Full Year 2025 Adjusted EPS Guidance … Updates FY 2025 GAAP EPS guidance to 'approximately $12.26' from the previous estimate of 'approximately $13.77'; affirms Adjusted FY 2025 EPS guidance of 'approximately $17.00' release 2025-11-05 | |||
| Diluted EPS Fiscal 2025 (ended 2025-12-31) |
Given $15.88 release 2025-02-11
Lowered $14.68 release 2025-04-30
Lowered $13.77 release 2025-07-30
Lowered $12.26 release 2025-11-05
|
$9.84 10-K filed 2026-02-19 |
Below the range |
The company's wordsProvides Full Year 2025 Financial Guidance … Affirms previous commentary of Adjusted FY 2025 EPS guidance to be 'at least in line with 2024 results'; anticipating GAAP EPS of approximately $15.88, or approximately $16.25 on an Adjusted basis, inclusive of incremental investments to support operational excellence release 2025-02-11 Affirms Full Year 2025 Adjusted Financial Guidance … Affirms Adjusted FY 2025 EPS guidance of 'approximately $16.25'; while revising GAAP EPS to 'approximately $14.68' from the previous estimate of 'approximately $15.88' release 2025-04-30 Updates FY 2025 GAAP EPS guidance to 'approximately $13.77' from the previous estimate of 'approximately $14.68'; raises Adjusted FY 2025 EPS guidance to 'approximately $17.00', up from the previous 'approximately $16.25' guidance release 2025-07-30 Updates FY 2025 GAAP EPS guidance to 'approximately $12.26' from the previous estimate of 'approximately $13.77'; affirms Adjusted FY 2025 EPS guidance of 'approximately $17.00' release 2025-11-05 | |||
| Revenue (company-defined) Fiscal 2025 (ended 2025-12-31) |
Given $126.00B to $128.00B release 2025-02-11
|
– | No standard number |
The company's wordsAccordingly, today we provided Adjusted EPS guidance for 2025 of ‘approximately $16.25’, inclusive of the investments described above, which is consistent with our previous commentary of ‘at least in line with 2024 results’. Our guidance assumes consolidated revenue in a range of $126 to $128 billion, reflecting approximately 8% year over year growth at the midpoint. release 2025-02-11 | |||
| Revenue Fiscal 2025 (ended 2025-12-31) |
Given $126.00B to $128.00B release 2025-02-11
Changed at least $128.00B release 2025-07-30
|
$129.66B 10-K filed 2026-02-19 |
At or above the minimum |
The company's wordsAccordingly, today we provided Adjusted EPS guidance for 2025 of ‘approximately $16.25’, inclusive of the investments described above, which is consistent with our previous commentary of ‘at least in line with 2024 results’. Our guidance assumes consolidated revenue in a range of $126 to $128 billion, reflecting approximately 8% year over year growth at the midpoint. release 2025-02-11 Raises FY 2025 consolidated revenues guidance to 'at least $128 billion' compared to the previous guidance range of $126 billion to $128 billion release 2025-07-30 | |||
| Diluted EPS Fiscal 2024 (ended 2024-12-31) |
Given $14.87 release 2024-01-25
Lowered $13.93 release 2024-04-24
Lowered $12.81 release 2024-07-31
Changed at least $12.89 release 2024-10-30
|
$9.98 10-K filed 2025-02-20 |
Below the minimum |
The company's wordsAnnounces initial FY 2024 EPS guidance of 'approximately $14.87' on a GAAP basis, 'approximately $16.00' on an Adjusted basis; assumes the higher Medicare Advantage medical costs experienced in 4Q23 persist throughout 2024 release 2024-01-25 Humana revised its GAAP EPS guidance for the year ending December 31, 2024 (FY 2024) to approximately $13.93 from approximately $14.87, while affirming its Adjusted EPS guidance of approximately $16.00. release 2024-04-24 Humana revised its GAAP EPS guidance for the year ending December 31, 2024 (FY 2024) to approximately $12.81 from approximately $13.93, while affirming its Adjusted EPS guidance of approximately $16.00. release 2024-07-31 Humana updates its GAAP EPS guidance for the year ending December 31, 2024 (FY 2024) to 'at least $12.89', or 'at least $16.00' on an Adjusted basis. release 2024-10-30 | |||
| Diluted EPS (company-defined) Fiscal 2024 (ended 2024-12-31) |
Given $16.00 release 2024-01-25
Kept $16.00 release 2024-04-24
Kept $16.00 release 2024-07-31
Changed at least $16.00 release 2024-10-30
|
– | No standard number |
The company's wordsOur initial 2024 Adjusted EPS outlook of ‘approximately $16’ assumes these higher costs persist throughout 2024, which we believe is prudent, as initial claims data suggests they are not seasonal or short term in nature. release 2024-01-25 Affirms Full Year Adjusted 2024 Financial Guidance … Revises FY 2024 EPS guidance to 'approximately $13.93' (previously 'approximately $14.87') on a GAAP basis, while affirming Adjusted EPS of 'approximately $16.00'; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent release 2024-04-24 Affirms Full Year Adjusted 2024 Financial Guidance … Revises FY 2024 EPS guidance to 'approximately $12.81' (previously 'approximately $13.93') on a GAAP basis, while affirming Adjusted EPS of 'approximately $16.00'; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent release 2024-07-31 Our performance to date allows us to update our 2024 Adjusted EPS outlook to ‘at least $16.00’ from our previous guidance of ‘approximately $16.00’, while also contemplating additional investments to support long-term value creation release 2024-10-30 | |||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (13 releases since 2023-11-01), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Work on HUM in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/HUM/export.csv") into a cell.